Evidence map›Paper›PMID 18971269›Full record

ArticleJournal of virology2009

Varicella-zoster virus immediate-early 63 protein interacts with human antisilencing function 1 protein and alters its ability to bind histones h3.1 and h3.3.

Aruna P Ambagala, Trent Bosma, Mir A Ali, Maxim Poustovoitov, Jason J Chen, Michael D Gershon, Peter D Adams, Jeffrey I Cohen

Abstract read
In one paragraph

Article in Journal of virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Varicella zoster virus infection.Nature reviews. Disease primers · 2015
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Varicella-zoster.Handbook of clinical neurology · 2014
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Aruna P AmbagalaLaboratory of Clinical Infectious Diseases, National Institutes of Health, 10 Center Dr., Building 10, Room 11N234, Bethesda, MD 20892, USA. jcohen@niaid.nih.gov
Trent Bosma
Mir A Ali
Maxim Poustovoitov
Jason J Chen
Michael D Gershon
Peter D Adams
Jeffrey I Cohen
National Institutes of Health · USColumbia University · USFox Chase Cancer Center · US

Funding

Molecular Biology Of Varicella Zoster Virus InfectionZIAAI000430 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI COHEN, JEFFREY · 2009 to 2025
$4.5M
INVESTIGATION OF A PUTATIVE NOVEL CYCLIN/CDK2 SUBSTRATER01GM062281 · NIGMS · RESEARCH INST OF FOX CHASE CAN CTR · PI ENDERS, GREGORY H. · 2001 to 2009
$2.6M
Intramural NIH HHSNIGMS NIH HHS R01 GM062281
6 · The paper itself

Abstract

Varicella-zoster virus (VZV) immediate-early 63 protein (IE63) is abundantly expressed during both acute infection in vitro and latent infection in human ganglia. Using the yeast two-hybrid system, we found that VZV IE63 interacts with human antisilencing function 1 protein (ASF1). ASF1 is a nucleosome assembly factor which is a member of the H3/H4 family of histone chaperones. IE63 coimmunoprecipitated and colocalized with ASF1 in transfected cells expressing IE63 and in VZV-infected cells. IE63 also colocalized with ASF1 in both lytic and latently VZV-infected enteric neurons. ASF1 exists in two isoforms, ASF1a and ASF1b, in mammalian cells. IE63 preferentially bound to ASF1a, and the amino-terminal 30 amino acids of ASF1a were critical for its interaction with IE63. VZV IE63 amino acids 171 to 208 and putative phosphorylation sites of IE63, both of which are critical for virus replication and latency in rodents, were important for the interaction of IE63 with ASF1. Finally, we found that IE63 increased the binding of ASF1 to histone H3.1 and H3.3, which suggests that IE63 may help to regulate levels of histones in virus-infected cells. Since ASF1 mediates eviction and deposition of histones during transcription, the interaction of VZV IE63 with ASF1 may help to regulate transcription of viral or cellular genes during lytic and/or latent infection.

Indexed as

Protein Interaction MappingVirus LatencyVirus ReplicationAnimalsCell Cycle ProteinsCell LineCells, CulturedGangliaGene Expression Regulation, ViralGuinea PigsHerpesvirus 3, HumanHistonesHumansImmediate-Early ProteinsImmunoprecipitationMaleASF1A protein, humanCell Cycle ProteinsHistonesimmediate early protein 63, Human herpesvirus 3Immediate-Early ProteinsMolecular ChaperonesViral Envelope Proteins

Identifiers

PMID18971269
PMCPMC2612320
OpenAlexW2110360074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.